AE Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13M Buy
206,603
+28,720
+16% +$2.3M 0.07% 263
2025
Q4
$17M Buy
177,883
+163,615
+1,147% +$16M 0.1% 214
2025
Q3
$1.39M Sell
14,268
-5,598
-28% -$580K 0.01% 669
2025
Q2
$2.13M Buy
19,866
+1,280
+7% +$130K 0.02% 522
2025
Q1
$1.87M Sell
18,586
-47,676
-72% -$4.8M 0.02% 544
2024
Q4
$5.92M Buy
66,262
+3,607
+6% +$318K 0.05% 314
2024
Q3
$5.25M Buy
62,655
+46,394
+285% +$3.66M 0.05% 322
2024
Q2
$1.25M Buy
16,261
+2,582
+19% +$189K 0.01% 650
2024
Q1
$937K Sell
13,679
-20,981
-61% -$1.35M 0.01% 662
2023
Q4
$2.12M Buy
34,660
+286
+0.8% +$15.3K 0.01% 884
2023
Q3
$1.81M Buy
34,374
+3,091
+10% +$162K 0.01% 881
2023
Q2
$1.69M Buy
31,283
+4,887
+19% +$255K 0.01% 891
2023
Q1
$1.32M Buy
26,396
+20,033
+315% +$944K 0.01% 940
2022
Q4
$294K Sell
6,363
-1,291
-17% -$55.9K ﹤0.01% 1507
2022
Q3
$296K Buy
7,654
+1,841
+32% +$73.9K ﹤0.01% 1479
2022
Q2
$217K Sell
5,813
-1,220
-17% -$49.7K ﹤0.01% 1569
2022
Q1
$311K Buy
7,033
+620
+10% +$26.9K ﹤0.01% 1402
2021
Q4
$272K Sell
6,413
-444
-6% -$18.7K ﹤0.01% 1482
2021
Q3
$298K Sell
6,857
-31,318
-82% -$1.39M ﹤0.01% 1363
2021
Q2
$1.63M Sell
38,175
-33,156
-46% -$1.39M 0.01% 690
2021
Q1
$2.76M Sell
71,331
-107
-0.1% -$4.05K 0.03% 481
2020
Q4
$2.57M Buy
71,438
+24,259
+51% +$874K 0.03% 429
2020
Q3
$1.8M Buy
47,179
+43
+0.1% +$1.66K 0.03% 459
2020
Q2
$1.66M Buy
47,136
+5,292
+13% +$191K 0.03% 466
2020
Q1
$1.36M Buy
41,844
+35,732
+585% +$1.4M 0.03% 410
2019
Q4
$276K Sell
6,112
-72
-1% -$3.01K 0.01% 933
2019
Q3
$252K Sell
6,184
-2,398
-28% -$102K 0.01% 844
2019
Q2
$369K Buy
+8,582
New +$330K 0.01% 677

Other funds holding BSX